Cibc World Markets Corp Bristol Myers Squibb CO Transaction History

Cibc World Markets Corp

$15 Billion
Q2 2024

A detailed history of Cibc World Markets Corp transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Cibc World Markets Corp holds 261,289 shares of BMY stock, worth $13.3 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares

261,289

Previous 204,049 28.05%

Holding current value

$13.3 Million

Previous $11.1 Million 1.93%

% of portfolio

0.07%

Previous 0.07%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$40.25 - $52.99 $2.3 Million - $3.03 Million	57,240 Added 28.05%	261,289 $10.9 Million
Q1 2024 May 13, 2024	SELL	$47.98 - $54.4 $32 Million - $36.3 Million	-667,374 Reduced 76.58%	204,049 $11.1 Million
Q4 2023 Feb 13, 2024	BUY	$48.48 - $57.85 $1.9 Million - $2.26 Million	39,117 Added 4.7%	871,423 $44.7 Million
Q3 2023 Nov 13, 2023	BUY	$57.89 - $64.73 $33.9 Million - $37.9 Million	586,100 Added 238.05%	832,306 $48.3 Million
Q2 2023 Aug 04, 2023	BUY	$63.71 - $70.74 $4.96 Million - $5.51 Million	77,843 Added 46.24%	246,206 $15.7 Million
Q1 2023 May 11, 2023	SELL	$65.71 - $74.53 $8.81 Million - $9.99 Million	-134,100 Reduced 44.34%	168,363 $11.7 Million
Q4 2022 Feb 09, 2023	BUY	$68.48 - $81.09 $11 Million - $13 Million	160,064 Added 112.41%	302,463 $21.8 Million
Q3 2022 Nov 14, 2022	SELL	$0.13 - $76.84 $810 - $478,790	-6,231 Reduced 4.19%	142,399 $10.1 Million
Q2 2022 Aug 12, 2022	SELL	$72.62 - $79.98 $21.8 Million - $24 Million	-299,793 Reduced 66.85%	148,630 $11.4 Million
Q1 2022 May 13, 2022	BUY	$61.48 - $73.72 $1.83 Million - $2.2 Million	29,812 Added 7.12%	448,423 $32.7 Million
Q4 2021 Feb 11, 2022	SELL	$53.63 - $62.52 $4.44 Million - $5.18 Million	-82,790 Reduced 16.51%	418,611 $26.1 Million
Q3 2021 Nov 12, 2021	BUY	$59.17 - $69.31 $20.5 Million - $24 Million	346,295 Added 223.26%	501,401 $29.7 Million
Q2 2021 Aug 10, 2021	SELL	$61.91 - $67.42 $3.62 Million - $3.94 Million	-58,492 Reduced 27.38%	155,106 $10.4 Million
Q1 2021 May 07, 2021	SELL	$59.34 - $66.74 $12 Million - $13.5 Million	-202,784 Reduced 48.7%	213,598 $13.5 Million
Q4 2020 Feb 12, 2021	BUY	$57.74 - $65.43 $8.37 Million - $9.48 Million	144,947 Added 53.4%	416,382 $25.8 Million
Q3 2020 Nov 12, 2020	SELL	$57.43 - $63.64 $34.9 Million - $38.6 Million	-607,014 Reduced 69.1%	271,435 $16.4 Million
Q2 2020 Aug 12, 2020	BUY	$54.82 - $64.09 $34.8 Million - $40.7 Million	635,185 Added 261.11%	878,449 $51.7 Million
Q1 2020 May 12, 2020	SELL	$46.4 - $67.43 $17.1 Million - $24.9 Million	-369,207 Reduced 60.28%	243,264 $13.6 Million
Q4 2019 Feb 13, 2020	BUY	$49.21 - $64.19 $1.08 Million - $1.41 Million	21,938 Added 3.71%	612,471 $39.3 Million
Q3 2019 Nov 12, 2019	BUY	$42.77 - $50.71 $9.27 Million - $11 Million	216,774 Added 58.0%	590,533 $29.9 Million
Q2 2019 Aug 13, 2019	SELL	$44.62 - $49.34 $832,787 - $920,881	-18,664 Reduced 4.76%	373,759 $17 Million
Q1 2019 May 14, 2019	SELL	$45.12 - $53.8 $6.18 Million - $7.37 Million	-136,944 Reduced 25.87%	392,423 $18.7 Million
Q4 2018 Feb 13, 2019	BUY	$48.76 - $63.23 $3.81 Million - $4.94 Million	78,140 Added 17.32%	529,367 $27.5 Million
Q3 2018 Nov 13, 2018	SELL	$55.19 - $62.25 $52.5 Million - $59.2 Million	-951,492 Reduced 67.83%	451,227 $28 Million
Q2 2018 Aug 13, 2018	BUY	$50.53 - $62.98 $55.6 Million - $69.3 Million	1,100,089 Added 363.51%	1,402,719 $77.6 Million
Q1 2018 May 11, 2018	SELL	$59.92 - $68.98 $3.7 Million - $4.26 Million	-61,748 Reduced 16.95%	302,630 $19.1 Million
Q4 2017 Feb 13, 2018	BUY	$59.94 - $65.35 $6.73 Million - $7.34 Million	112,277 Added 44.54%	364,378 $22.3 Million
Q3 2017 Nov 14, 2017	BUY	$55.23 - $63.74 $13.9 Million - $16.1 Million	252,101	252,101 $16.1 Million

Others Institutions Holding BMY

# of Institutions

2,400

Shares Held

1.5B

Call Options Held

29.7M

Put Options Held

32.2M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $108B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cibc World Markets Corp, based on Form 13F filings with the SEC.

News

Stay updated on Cibc World Markets Corp with notifications on news.

Account

Cibc World Markets Corp Bristol Myers Squibb CO Transaction History